What are B-cell receptor agents? How can they help in chronic lymphocytic leukemia (CLL) treatment? There are several new drugs, B-cell receptor agents, now in clinical trials. Could they be the start of a new age in the treatment of CLL? Dr. Susan O'Brien from the MD Anderson Cancer Center in Houston shared her thoughts from the 9th European Congress on Hematologic Malignancies in Lyon, France.
Watch now as Dr. O'Brien explains how the science behind these new drugs is promising for CLL patients.